Position in CYTK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,591,000
+$1,825,500 QoQ
Shares Held
100,000
+33.3% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
4.55%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Monashee Investment Management LLC holds $73,502,476 across 18 Biotechnology names. CYTK ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
300,000 | $15,816,000 | |
| 2 | SLDB |
Solid Biosciences Inc.
|
1,420,295 | $10,226,124 | |
| 3 | NKTR |
Nektar Therapeutics
|
100,000 | $7,195,000 | |
| 4 | CYTK |
Cytokinetics Inc
This page
|
100,000 | $6,591,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
67,139 | $4,985,742 | |
| 6 | EVMN |
Evommune, Inc.
|
179,340 | $4,123,026 | |
| 7 | MANE |
Veradermics, Inc
|
50,000 | $3,157,500 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
150,000 | $2,932,500 |
All Filings in CYTK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,591,000 | 100,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,765,500 | 75,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,496,000 | 100,000 | Shares | Sole | 2025-11-12 | |
| 2022-06-30 | $1,768,050 | 45,000 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||